Decitabine (Dacogen)

DRUG2 trials

Sponsors

University of Utah, Eisai Inc.

Conditions

AMLAcute Myeloid LeukemiaLeukemia

Phase 1

Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients

CompletedNCT01149408

University of UtahAcute Myeloid Leukemia, AML

Start: 2011-02-28End: 2014-09-30Updated: 2015-10-07

Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

CompletedNCT01378416

Eisai Inc.Leukemia

Start: 2005-04-30End: 2007-06-30Updated: 2011-07-12